Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)

Clinical trial NCT01488578 · COMPLETED

Trial details

NCT number: NCT01488578
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Overactive Bladder

Start date: 2006-12-01
Primary completion: 2011-03-01
Enrollment: 11157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.